You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable Pancreatic Cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in New York, Seattle (Nivolumab + Cabiralizumab, Stereotactic Body Radiotherapy (SBRT))

Terminated
Has Results
  • Pancreatic Cancer
  • Nivolumab + Cabiralizumab
  • Stereotactic Body Radiotherapy (SBRT)
  • New York, New York
  • +1 more
Sep 22, 2021

Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Scottsdale (Paclitaxel Protein

Active, not recruiting
  • Resectable Pancreatic Cancer
  • +3 more
  • Paclitaxel Protein Bound (Abraxane)
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 15, 2022

Pancreatic Ductal Adenocarcinoma Trial in Hangzhou (EUS-RFA)

Completed
  • Pancreatic Ductal Adenocarcinoma
  • EUS-RFA
  • Hangzhou, Zhejiang, China
    Hangzhou First People's Hospital
Aug 27, 2021

Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester

Recruiting
  • Advanced Pancreatic Carcinoma
  • +9 more
  • Endoscopic Ultrasound
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 13, 2022

Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma Trial in Duarte

Recruiting
  • Stage III Pancreatic Cancer AJCC v8
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 9, 2021

Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic Trial in Baltimore (INCMGA00012 (PD-1 antibody))

Recruiting
  • Pancreatic Cancer Non-resectable
  • Pancreatic Cancer Metastatic
  • INCMGA00012 (PD-1 antibody)
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 16, 2022

Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy, Borderline Resectable Pancreatic Cancer Treated

Recruiting
  • Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
  • Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 15, 2021

Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Sotorasib, Liposomal Irinotecan

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • (no location specified)
Feb 11, 2022

Unresectable Pancreatic Cancer Trial in Louisville, Greenville (Bilateral Thoracoscopic Splanchnicectomy)

Withdrawn
  • Unresectable Pancreatic Cancer
  • Bilateral Thoracoscopic Splanchnicectomy
  • Louisville, Kentucky
  • +1 more
Jun 17, 2021

Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • LB1908
  • (no location specified)
Sep 9, 2022

Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in United States

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • +3 more
  • Gemcitabine Hydrochloride
  • +5 more
  • Duarte, California
  • +3 more
Mar 17, 2022

Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City

Recruiting
  • Metastatic Pancreatic Carcinoma
  • +6 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Oct 31, 2022

Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC

Recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • +7 more
  • Gemcitabine Hydrochloride
  • +8 more
  • Philadelphia, Pennsylvania
  • +1 more
Dec 20, 2022

Pancreatic Cancer Trial in China (AK104, Gemcitabine, Nab-Paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • Beijing, Beijing, China
  • +6 more
May 5, 2023

Unresectable Locally Advanced Pancreatic Cancer Trial in Shanghai (Sintilimab; Gemcitabine; Albumin-paclitaxel)

Recruiting
  • Unresectable Locally Advanced Pancreatic Cancer
  • Sintilimab; Gemcitabine; Albumin-paclitaxel
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Apr 20, 2022

SBRT, Borderline Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer Trial in Worldwide (Drug GC4711, Placebo)

Recruiting
  • SBRT
  • +2 more
  • Drug GC4711
  • Placebo
  • Gilbert, Arizona
  • +23 more
Aug 12, 2022

NSCLC, Advanced Pancreatic Adenocarcinoma, Unresectable Pancreatic Cancer Trial in Boston (AGuIX, Radiotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 25, 2021

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Genetic, Microenvironmental, and Immunological Factors in

Recruiting
  • Pancreas Cancer
    • Rome, Lazio, Italy
      "Agostino Gemelli" Hospital, Catholic University of Sacred Heart
    Apr 4, 2022

    Locally Advanced Pancreatic Adenocarcinoma Trial in Dallas, Chiba (Carbon Ion Radiation Therapy (CIRT), Intensity Modulated

    Withdrawn
    • Locally Advanced Pancreatic Adenocarcinoma
    • Carbon Ion Radiation Therapy (CIRT)
    • Intensity Modulated Radiation Therapy (IMRT)
    • Dallas, Texas
    • +1 more
    May 24, 2021

    Unresectable Pancreatic Cancer Trial in Aalborg (IRE)

    Recruiting
    • Unresectable Pancreatic Cancer
    • IRE
    • Aalborg, Denmark
      Aalborg University Hospital
    Mar 31, 2021

    Pancreatic Cancer Trial in Baltimore, Dallas (ARQ-761, Gemcitabine, nab-paclitaxel)

    Terminated
    • Pancreatic Cancer
    • Baltimore, Maryland
    • +1 more
    May 31, 2022

    Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

    Recruiting
    • Colorectal Adenocarcinoma
    • +13 more
    • Nanoliposomal Irinotecan
    • Trifluridine and Tipiracil Hydrochloride
    • Atlanta, Georgia
    • +2 more
    Jan 6, 2023

    Breast Cancer Metastatic, Pancreatic Cancer, NSCLC, Metastatic Trial in Denver, Grand Rapids (ST316)

    Not yet recruiting
    • Breast Cancer Metastatic
    • +7 more
    • Denver, Colorado
    • +1 more
    Apr 28, 2023

    Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Colorectal Cancer Trial in United States (Usual chemo

    Completed
    Has Results
    • Metastatic Pancreatic Cancer
    • +2 more
    • Usual chemotherapy education (CE)
    • Chemotherapy education intervention (CEI)
    • Tampa, Florida
    • +4 more
    Dec 21, 2021